x

Replimune Group, Inc. (Nasdaq:REPL)

Health Care/Life Sciences • Pharmaceuticals
CIK 1737953
Company

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Address
500 Unicorn Park Drive
Suite 303
3rd Floor
Woburn, Massachusetts 01801
Employees
331
Stock Info
Close
$12.29
Day Range
11.69 - 12.32
52 Week Range
4.92 - 17.00
Average volume
741.39K
Short Interest
9.08M (02/14/25)
% of Float Shorted
14.76%
Market Cap
$946.51M
Revenue
N/A
Net Income
-$215.79M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$3.14
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Chief Executive Officer & Director
Sushil Patel
Director
Madhavan Balachandran
Independent Director
Kapil Dhingra
Independent Director
Christy J. Oliger
Independent Director
Joseph P. Slattery
Independent Director
Paolo Pucci
Independent Director
Veleka R. Peeples-Dyer
SEC filings
DateFormEvent
20 Dec, 2024 S-8
18 Dec, 2024 4
16 Dec, 2024 144
4 Dec, 2024 8-K/A
27 Nov, 2024 8-K
26 Nov, 2024 424B5
26 Nov, 2024 8-K
25 Nov, 2024 424B5
21 Nov, 2024 8-K
20 Nov, 2024 4
20 Nov, 2024 4
19 Nov, 2024 S-8
14 Nov, 2024 SC 13G/A
14 Nov, 2024 SC 13G/A
14 Nov, 2024 SC 13G/A
14 Nov, 2024 SC 13G/A
12 Nov, 2024 8-K
12 Nov, 2024 SC 13G/A
12 Nov, 2024 10-Q
4 Nov, 2024 SC 13G/A
16 Oct, 2024 S-8
7 Oct, 2024 SC 13G/A
5 Sep, 2024 3
5 Sep, 2024 8-K
5 Sep, 2024 4
30 Aug, 2024 4
19 Aug, 2024 4
14 Aug, 2024 EFFECT
13 Aug, 2024 CORRESP
9 Aug, 2024 UPLOAD
8 Aug, 2024 10-Q
8 Aug, 2024 8-K
8 Aug, 2024 S-3
22 Jul, 2024 EFFECT
19 Jul, 2024 ARS
19 Jul, 2024 DEF 14A
19 Jul, 2024 DEFA14A
10 Jul, 2024 SC 13G/A
13 Jun, 2024 8-K
10 Jun, 2024 4
7 Jun, 2024 144
6 Jun, 2024 8-K
3 Jun, 2024 8-K
23 May, 2024 144
20 May, 2024 4
20 May, 2024 4
20 May, 2024 4
20 May, 2024 4
20 May, 2024 4
20 May, 2024 4
20 May, 2024 4
16 May, 2024 10-K
16 May, 2024 POSASR
16 May, 2024 S-8
16 May, 2024 POS AM
16 May, 2024 8-K
10 Apr, 2024 SC 13G/A
10 Apr, 2024 SC 13G/A
3 Apr, 2024 4
3 Apr, 2024 4
3 Apr, 2024 4
3 Apr, 2024 4
3 Apr, 2024 4
3 Apr, 2024 4
3 Apr, 2024 4
3 Apr, 2024 4
3 Apr, 2024 4
3 Apr, 2024 4
3 Apr, 2024 4
3 Apr, 2024 4
26 Mar, 2024 8-K CEO Change
14 Feb, 2024 SC 13G/A
14 Feb, 2024 SC 13G/A
14 Feb, 2024 SC 13G/A
14 Feb, 2024 SC 13G/A
9 Feb, 2024 SC 13G
8 Feb, 2024 10-Q
8 Feb, 2024 8-K
26 Jan, 2024 SC 13G/A
25 Jan, 2024 SC 13G
10 Jan, 2024 SC 13G/A
8 Jan, 2024 8-K
26 Dec, 2023 8-K
5 Dec, 2023 8-K
17 Nov, 2023 4
17 Nov, 2023 4
7 Nov, 2023 8-K
7 Nov, 2023 10-Q
20 Sep, 2023 3
20 Sep, 2023 4
19 Sep, 2023 8-K
13 Sep, 2023 4
7 Sep, 2023 8-K
24 Aug, 2023 4
15 Aug, 2023 4
3 Aug, 2023 8-K
3 Aug, 2023 10-Q
3 Aug, 2023 S-3ASR
3 Aug, 2023 8-K
26 Jul, 2023 DEF 14A
26 Jul, 2023 DEFA14A
26 Jul, 2023 3
26 Jul, 2023 ARS
20 Jul, 2023 8-K
11 Jul, 2023 4
10 Jul, 2023 144
15 Jun, 2023 4
15 Jun, 2023 4
13 Jun, 2023 144
13 Jun, 2023 144
5 Jun, 2023 4
5 Jun, 2023 8-K
5 Jun, 2023 3
18 May, 2023 8-K
18 May, 2023 S-8
18 May, 2023 4
18 May, 2023 4
18 May, 2023 4
18 May, 2023 4
18 May, 2023 4
18 May, 2023 4
18 May, 2023 4
18 May, 2023 4
18 May, 2023 3
18 May, 2023 10-K
4 Apr, 2023 4
4 Apr, 2023 4
4 Apr, 2023 4
4 Apr, 2023 4
4 Apr, 2023 4
4 Apr, 2023 4
4 Apr, 2023 4
4 Apr, 2023 4
4 Apr, 2023 4
4 Apr, 2023 4
4 Apr, 2023 4
4 Apr, 2023 4
4 Apr, 2023 4
4 Apr, 2023 4
4 Apr, 2023 4
27 Feb, 2023 8-K
14 Feb, 2023 SC 13G/A
14 Feb, 2023 SC 13G/A
14 Feb, 2023 SC 13G
13 Feb, 2023 SC 13G/A
9 Feb, 2023 10-Q
9 Feb, 2023 8-K
3 Feb, 2023 SC 13G
4 Jan, 2023 8-K
13 Dec, 2022 4
12 Dec, 2022 424B5
12 Dec, 2022 8-K
7 Dec, 2022 424B5
7 Dec, 2022 8-K
6 Dec, 2022 SC 13D/A
5 Dec, 2022 3
5 Dec, 2022 4
18 Nov, 2022 SC 13G/A
3 Nov, 2022 10-Q
3 Nov, 2022 8-K
7 Oct, 2022 8-K
14 Sep, 2022 SC 13D/A
8 Sep, 2022 8-K
4 Aug, 2022 8-K
4 Aug, 2022 10-Q
27 Jul, 2022 DEFA14A
27 Jul, 2022 CORRESP
27 Jul, 2022 DEF 14A
27 Jul, 2022 EFFECT
30 Jun, 2022 UPLOAD
23 Jun, 2022 S-3
23 Jun, 2022 8-K
3 Jun, 2022 8-K
19 May, 2022 8-K
19 May, 2022 10-K
18 May, 2022 4
18 May, 2022 4
18 May, 2022 4
18 May, 2022 4
18 May, 2022 4
18 May, 2022 4
18 May, 2022 4
5 Apr, 2022 4
5 Apr, 2022 4
5 Apr, 2022 4
5 Apr, 2022 4
5 Apr, 2022 4
5 Apr, 2022 4
5 Apr, 2022 4
5 Apr, 2022 4
5 Apr, 2022 4
5 Apr, 2022 4
5 Apr, 2022 4
5 Apr, 2022 4
5 Apr, 2022 4
5 Apr, 2022 4
5 Apr, 2022 4
30 Mar, 2022 8-K
16 Mar, 2022 4
14 Feb, 2022 SC 13G/A
14 Feb, 2022 SC 13G/A
14 Feb, 2022 SC 13G/A
9 Feb, 2022 SC 13G/A
3 Feb, 2022 8-K
3 Feb, 2022 10-Q
31 Jan, 2022 8-K
10 Jan, 2022 8-K
3 Dec, 2021 4
3 Dec, 2021 3
2 Dec, 2021 8-K
23 Nov, 2021 4
18 Nov, 2021 4
18 Nov, 2021 4
16 Nov, 2021 4
12 Nov, 2021 4
10 Nov, 2021 4
8 Nov, 2021 4
4 Nov, 2021 10-Q
4 Nov, 2021 8-K
19 Oct, 2021 4
27 Sep, 2021 4
20 Sep, 2021 4
17 Sep, 2021 4
9 Sep, 2021 8-K
25 Aug, 2021 8-K
18 Aug, 2021 4
18 Aug, 2021 CT ORDER
6 Aug, 2021 8-K
6 Aug, 2021 10-Q
6 Aug, 2021 4
22 Jul, 2021 DEF 14A
22 Jul, 2021 4
22 Jul, 2021 DEFA14A
19 Jul, 2021 4
19 Jul, 2021 4/A
16 Jul, 2021 4
12 Jul, 2021 SC 13G/A
7 Jul, 2021 4
30 Jun, 2021 4
16 Jun, 2021 4
3 Jun, 2021 8-K
20 May, 2021 S-8
20 May, 2021 10-K
20 May, 2021 8-K
11 May, 2021 4
10 May, 2021 8-K
5 May, 2021 4
5 May, 2021 8-K
5 May, 2021 3
21 Apr, 2021 8-K
19 Apr, 2021 4
12 Apr, 2021 8-K
5 Apr, 2021 4
5 Apr, 2021 4
5 Apr, 2021 4
5 Apr, 2021 4
5 Apr, 2021 4
5 Apr, 2021 4
5 Apr, 2021 4
5 Apr, 2021 4
5 Apr, 2021 4
5 Apr, 2021 4
5 Apr, 2021 4
5 Apr, 2021 4
5 Apr, 2021 4
5 Apr, 2021 4
5 Apr, 2021 4
17 Mar, 2021 4
18 Feb, 2021 4
16 Feb, 2021 SC 13G/A
16 Feb, 2021 SC 13G/A
16 Feb, 2021 SC 13G/A
16 Feb, 2021 SC 13G
16 Feb, 2021 SC 13G/A
11 Feb, 2021 SC 13G/A
11 Feb, 2021 4
8 Feb, 2021 SC 13G
4 Feb, 2021 8-K
4 Feb, 2021 10-Q
28 Jan, 2021 4
28 Jan, 2021 4
26 Jan, 2021 4
26 Jan, 2021 4
19 Jan, 2021 4
19 Jan, 2021 4
19 Jan, 2021 4
19 Jan, 2021 4
15 Jan, 2021 4
11 Jan, 2021 8-K
Last update:2025-03-06 12:02:21.063988
Replimune Group, Inc. by TradingView

Sign Up to Subscribe